Division of Infectious Diseases Archive — Page 4 of 13
-
April 25, 2023
COVID alters respiratory microbiota
COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions. -
March 9, 2023
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. -
February 23, 2023
NIH grant supports TB research network in Brazil
The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil. -
February 8, 2023
New Chief Medical Officers announced
Rick W. Wright, MD, has been appointed as Vanderbilt University Medical Center’s new Chief Medical Officer (CMO) and Senior Vice President for Clinical Affairs and Patty Wright, MD, will be transitioning from her role as Chief of Staff for Adult Ambulatory, Davidson County to the role of Chief Medical Officer for Adult Ambulatory Clinics. -
February 6, 2023
Gut microbiota and lung fibrosis
Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients. -
February 2, 2023
COVID-19 battle begins in the nose
A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered. -
February 2, 2023
Risk of household flu spread skyrocketed during pandemic
A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.